Safety Shot Responds to FSD Pharma’s 3rd unauthorized Tagging of its Stock and Making False Claims in an Effort to Harm the Company and its Shareholders
17 Janvier 2024 - 2:00PM
Safety Shot, Inc. (Nasdaq: SHOT)
today announced that a federal court has refused to dismiss GBB Lab
Inc.’s (GBB) ongoing lawsuit against FSD Pharma. FSD Pharma, a
clinical-stage biotech company, has violated a Non-Disclosure
Agreement (NDA) with GBB and has breached the contract by
attempting to steal information and launch GBB’s product without
permission. The lawsuit is between FSD Pharma and GBB only. Safety
Shot continues with the national launch of its highly anticipated
and well received wellness beverage which helps people feel better
faster by reducing blood alcohol content and boosting clarity.
The federal court’s statements regarding the
FSD-GBB case include:
"Nowhere in the
Amended Complaint does Plaintiff allege that all nineteen of the
ingredients are necessary to create a parallel program or
competitor drink, and this Court sees no reason to impose such a
requirement. It is apparent, at least to this Court, that Plaintiff
takes issue with Defendants’ development of a competing drink,
which relies on most of the same ingredients (and methods for
combining such ingredients) as Plaintiff’s proprietary
beverage”
“Drawing all
inferences in Plaintiff’s favor, this Court concludes that
Plaintiff has sufficiently demonstrated that its trade secrets
derived economic value from not being readily ascertainable by
others. Plaintiff alleges that the unidentified investors pulled
out of the contemplated deals ‘because of Defendants’ announcements
(and the promotional content) related to the development and
planned future launch of a competing product that utilizes GBB’s
confidential information.’”
GBB CEO John Gulyas said, “The Court’s decision
to not dismiss GBB’s case demonstrates that we have a strong legal
position based on the facts. We look forward to a full and fair
proceeding to resolve this matter and we believe that we will be
victorious.”
FSD Pharma continues to unauthorized tag the
Company’s stock ticker “SHOT” in an effort to harm it and its
shareholders by making false claims.
About Safety Shot
Safety Shot, a wellness and functional beverage
company, is set to launch Safety Shot, the first patented beverage
on Earth that helps people feel better faster by reducing blood
alcohol content and boosting clarity. Safety Shot has been
available for retail purchase in the first week of December 2023 at
www.DrinkSafetyShot.com and www.Amazon.com. The Company plans to
launch business-to-business sales of Safety Shot to distributors,
retailers, restaurants, and bars in the first quarter of 2024.
Safety Shot plans to spin off legacy assets from its Jupiter
Wellness business to unlock value for shareholders.
Forward Looking Statements
This communication contains forward-looking
statements regarding Safety Shot, including, the anticipated timing
of studies and the results and benefits thereof. You can generally
identify forward-looking statements by the use of forward-looking
terminology such as “anticipate,” “believe,” “continue,” “could,”
“estimate,” “expect,” “explore,” “evaluate,” “intend,” “may,”
“might,” “plan,” “potential,” “predict,” “project,” “seek,”
“should,” or “will,” or the negative thereof or other variations
thereon or comparable terminology. These forward-looking statements
are based on each of the Company’s current plans, objectives,
estimates, expectations, and intentions and inherently involve
significant risks and uncertainties, many of which are beyond
Safety Shot’s control. Actual results and the timing of events
could differ materially from those anticipated in such
forward-looking statements as a result of these risks and
uncertainties and other risks and uncertainties affecting Safety
Shot and, including those described from time to time under the
caption “Risk Factors” and elsewhere in Safety Shot’s Securities
and Exchange Commission (SEC) filings and reports, including Safety
Shot’s Annual Report on Form 10-K for the year ended December 31,
2023 and future filings and reports by Safety Shot. Moreover, other
risks and uncertainties of which the combined company is not
currently aware may also affect each of the companies’
forward-looking statements and may cause actual results and the
timing of events to differ materially from those anticipated.
Investors are cautioned that forward-looking statements are not
guarantees of future performance. The forward-looking statements
made in this communication are made only as of the date hereof or
as of the dates indicated in the forward-looking statements and
reflect the views stated therein with respect to future events at
such dates, even if they are subsequently made available by Safety
Shot on its website or otherwise. Safety Shot undertakes no
obligation to update or supplement any forward-looking statements
to reflect actual results, new information, future events, changes
in its expectations or other circumstances that exist after the
date as of which the forward-looking statements were made.
Media Contact:Phone: 904-477-2306Email:
emily@pantelidespr.com
Investor Contact: Phone:
561-244-7100Email: investors@safetyshotholdings.com
###
Safety Shot (NASDAQ:SHOT)
Graphique Historique de l'Action
De Jan 2025 à Fév 2025
Safety Shot (NASDAQ:SHOT)
Graphique Historique de l'Action
De Fév 2024 à Fév 2025